Search results for "GLP-1"

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s Ministry of Food and Drug...
'Natural Wegovy' Is a Myth, Surgeon Warns, Pushing Back on Viral Diet Trend

'Natural Wegovy' Is a Myth, Surgeon Warns, Pushing Back on Viral Diet Trend

A viral social media trend promoting a "Natural Wegovy" diet—eating boiled eggs drizzled with olive oil—has prompted a practicing university hospital...
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes...
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1...
The GLP-1 Paradox: Wegovy and Mounjaro Patients Shed Weight, but Walk Less

The GLP-1 Paradox: Wegovy and Mounjaro Patients Shed Weight, but Walk Less

"First I’ll lose the weight, and then I’ll start exercising."It is a thought shared by almost anyone starting highly...
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...
The Ozempic Multiplier: Why Lifestyle Habits Still Dictate Heart Health in the GLP-1 Era

The Ozempic Multiplier: Why Lifestyle Habits Still Dictate Heart Health in the GLP-1 Era

It has been three months since I started my once-weekly Ozempic injection. My blood sugar is clearly under control, and...